Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2023-09-08 | Reverse | 1:30 |
IMAC Holdings, Inc. operates 15 outpatient clinics across the U.S. offering regenerative, orthopedic, minimally invasive treatments, physical therapy, and chiropractic care for sports injuries, joint pain, and soft tissue conditions.

IMAC Holdings, via Ignite Proteomics, provides a platform to quantify protein signaling, aiding oncologists in targeted cancer treatments and advancing the company's focus on precision oncology.
| Icon | PRODUCT | Q1-2021 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
![]() | Patient Revenues | $3.02M | — | — |
![]() | Operating Segments | — | $103.19K | $102.33K ▼ |
Overall rating: B-
| PEER | PRICE | |
|---|---|---|
PRE | $25.76 | COMPARE |
PIII | $9.22 | COMPARE |
ACON | $2.40 | COMPARE |
DRMA | $1.34 | COMPARE |
CERO | $0.01 | COMPARE |
OCEA | $0.00 | COMPARE |
PPBT | $1.68 | COMPARE |
NUWE | $0.89 | COMPARE |